| A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) (NCT01156961) | Hoffmann-La Roche | 2010-10-01 |
| Clinical Trial Comparing Outcomes of Breast Conserving Operations With Classic v High-frequency Electrocoagulation (NCT01216254) | Medical University of Gdansk | 2010-10-01 |
| Long-term Anastrozole Versus Tamoxifen Treatment Effects (NCT01745289) | Queen Mary University of London | 2010-10-01 |
| The Jewels in Our Genes Study - an African American Family Study of Breast Cancer (NCT01380925) | University at Buffalo | 2010-10-01 |
| Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET (NCT01224873) | Rigshospitalet, Denmark | 2010-10-01 |
| Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer (NCT01924078) | Fudan University | 2010-10-01 |
| Effect of Early vs Late Drainage Removal in Women After Radical Mastectomy With Axillary Clearance (NCT01221064) | Medical University of Gdansk | 2010-10-01 |
| Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer (NCT01199432) | Tao OUYANG | 2010-10-01 |
| A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3) (NCT01234857) | Merck Sharp & Dohme LLC | 2010-09-17 |
| Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer (NCT01105312) | Alliance for Clinical Trials in Oncology | 2010-09-01 |
| Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research (NCT01016886) | University of Alberta | 2010-09-01 |
| Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer (NCT01241721) | Swedish Medical Center | 2010-09-01 |
| Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer (NCT01208480) | Severance Hospital | 2010-09-01 |
| Prospective Radiologic Evaluation of Changes Following Fat Grafting (NCT01343030) | University of Minnesota | 2010-09-01 |
| ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging Devices (NCT01837225) | University Health Network, Toronto | 2010-09-01 |
| The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050) (NCT01220570) | Merck Sharp & Dohme LLC | 2010-09-01 |
| Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors (NCT01196936) | University of Alabama at Birmingham | 2010-09-01 |
| Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer (NCT01275859) | Asan Medical Center | 2010-09-01 |
| Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors (NCT01272570) | University of Michigan | 2010-09-01 |
| Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release (NCT01205503) | Mara Chambers | 2010-09-01 |
| Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer (NCT00925652) | Dana-Farber Cancer Institute | 2010-09-01 |
| Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer (NCT01203839) | Memorial Sloan Kettering Cancer Center | 2010-09-01 |
| Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer (NCT01356862) | Alliance Pour La Recherche en Cancerologie | 2010-09-01 |
| Molecular Triaging of Newly Diagnosed Breast Cancer (NCT01159236) | M.D. Anderson Cancer Center | 2010-09-01 |
| Assessing Treatment Response in Breast Cancer With Functional Imaging (NCT02688257) | Institute of Cancer Research, United Kingdom | 2010-09-01 |
| A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer (NCT01101438) | Canadian Cancer Trials Group | 2010-08-13 |
| Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses (NCT01540110) | National Cancer Centre, Singapore | 2010-08-11 |
| Rehabilitation of Cognitive Changes in Breast Cancer Survivors (NCT01182506) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| Lung Inflammation and Lung Metastases From Breast Cancer (NCT01182519) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery (NCT01314144) | Cork University Hospital | 2010-08-01 |
| Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies (NCT01142661) | Eisai Inc. | 2010-08-01 |
| Integrative Oncology Outcomes Study in Breast Cancer (NCT01366248) | Bastyr University | 2010-08-01 |
| Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms (NCT01227733) | National University Hospital, Singapore | 2010-08-01 |
| Art Therapy Intervention for Breast Cancer Patients (NCT01220960) | Dr. Sarkis Meterissian | 2010-08-01 |
| Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer (NCT01273415) | Samsung Medical Center | 2010-08-01 |
| Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy (NCT01053468) | Athabasca University | 2010-08-01 |
| Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy (NCT01160718) | Swiss Cancer Institute | 2010-08-01 |
| NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? (NCT01270373) | Instituto Nacional de Cancer, Brazil | 2010-08-01 |
| NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo (NCT01934114) | Dartmouth-Hitchcock Medical Center | 2010-08-01 |
| Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast Cancer (NCT01380912) | Copenhagen University Hospital at Herlev | 2010-08-01 |
| A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer (NCT01171417) | AstraZeneca | 2010-08-01 |
| Physical Activity, Fatigue, Sleep, and Inflammation (NCT01147367) | University of Alabama at Birmingham | 2010-08-01 |
| Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor (NCT01176799) | National University Hospital, Singapore | 2010-08-01 |
| Promoting a Healthier Lifestyle Among Breast Cancer Survivors (NCT01419613) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-01 |
| The Physical and Psychological Benefits of Yoga and Breast Cancer (NCT01230671) | Dr. Sarkis Meterissian | 2010-08-01 |
| A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE) (NCT01120184) | Hoffmann-La Roche | 2010-07-31 |
| Single Dose Partial Breast Radiotherapy (NCT00944528) | Duke University | 2010-07-28 |
| Metronomic Therapy in Metastatic Breast Cancer. (NCT01131195) | Swiss Cancer Institute | 2010-07-19 |
| QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA (NCT01147965) | NantCell, Inc. | 2010-07-16 |
| Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast Cancer (NCT01221688) | Institut Cancerologie de l'Ouest | 2010-07-12 |
| Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer (NCT04661982) | City of Hope Medical Center | 2010-07-06 |
| PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM) (NCT01192308) | Radboud University Medical Center | 2010-07-01 |
| BCRL Prevention Pilot (NCT01166672) | Abramson Cancer Center at Penn Medicine | 2010-07-01 |
| Personalised Program for Women Treated for Hodgkin Disease (NCT01188915) | Institut Paoli-Calmettes | 2010-07-01 |
| Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention (NCT01282580) | Ohio State University Comprehensive Cancer Center | 2010-07-01 |
| The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient (NCT01521000) | Main Line Health | 2010-07-01 |
| Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors (NCT01141868) | Milton S. Hershey Medical Center | 2010-07-01 |
| Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring (NCT01771497) | Koning Corporation | 2010-07-01 |
| A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer (NCT01163929) | University of Kansas | 2010-07-01 |
| Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening (NCT01910350) | Michigan State University | 2010-07-01 |
| Cardiotoxicity of Cancer Therapy (CCT) (NCT01173341) | Abramson Cancer Center at Penn Medicine | 2010-07-01 |
| Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer (NCT01105650) | Masonic Cancer Center, University of Minnesota | 2010-07-01 |
| Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer (NCT01331629) | Centre Francois Baclesse | 2010-07-01 |
| Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery (NCT01147016) | Barbara Ann Karmanos Cancer Institute | 2010-07-01 |
| Breast Health in Chinese American Women (NCT01292200) | Georgetown University | 2010-07-01 |
| Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment (NCT01273909) | The National Institute of Lymphology | 2010-07-01 |
| Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer (NCT01403779) | Universitätsmedizin Mannheim | 2010-07-01 |
| Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients (NCT01554943) | Jules Bordet Institute | 2010-07-01 |
| Re-expression of ER in Triple Negative Breast Cancers (NCT01194908) | Emory University | 2010-07-01 |
| A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors (NCT01171924) | Curis, Inc. | 2010-07-01 |
| Safety Study of MGAH22 in HER2-positive Carcinomas (NCT01148849) | MacroGenics | 2010-07-01 |
| Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients (NCT01306188) | Centre Leon Berard | 2010-07-01 |
| Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment (NCT01144572) | AstraZeneca | 2010-07-01 |
| Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers (NCT01360177) | Stanford University | 2010-07-01 |
| A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer (NCT01156753) | Celldex Therapeutics | 2010-07-01 |
| Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients (NCT04022616) | Ohio State University Comprehensive Cancer Center | 2010-06-04 |
| Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) (NCT01077154) | Amgen | 2010-06-02 |
| RAD001 Plus Carboplatin in Breast Cancer Patients (NCT01127763) | NYU Langone Health | 2010-06-01 |
| An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2) (NCT01277133) | Hoffmann-La Roche | 2010-06-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery (NCT01413269) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2010-06-01 |
| Academia Sinica Investigator Award 2010 (NCT01287468) | Taipei Medical University WanFang Hospital | 2010-06-01 |
| Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes (NCT01106040) | Navidea Biopharmaceuticals | 2010-06-01 |
| Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery (NCT01082211) | Radiation Therapy Oncology Group | 2010-06-01 |
| Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer (NCT01151215) | AstraZeneca | 2010-06-01 |
| Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer (NCT01290835) | Essentia Health | 2010-06-01 |
| The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer (NCT01159405) | SeeCure LLC | 2010-06-01 |
| Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer (NCT01047358) | Pfizer | 2010-06-01 |
| Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity (NCT01163552) | St. Luke's-Roosevelt Hospital Center | 2010-06-01 |
| Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer (NCT01194869) | Emory University | 2010-06-01 |
| A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients (NCT01210768) | TTY Biopharm | 2010-06-01 |
| Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer (NCT01068704) | Bristol-Myers Squibb | 2010-06-01 |
| A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy (NCT01152398) | Bavarian Nordic | 2010-06-01 |
| Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer (NCT01153282) | Abramson Cancer Center at Penn Medicine | 2010-06-01 |
| Excision Followed by Radiofrequency Ablation for Breast Cancer (NCT01153035) | University of Arkansas | 2010-06-01 |
| Intraoperative Radiotherapy for Early Stage Breast Cancer (NCT01189851) | Hoag Memorial Hospital Presbyterian | 2010-06-01 |
| Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer (NCT01082068) | Sanofi | 2010-06-01 |
| Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer (NCT01009437) | Masonic Cancer Center, University of Minnesota | 2010-05-26 |
| A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer (NCT01142778) | Hoffmann-La Roche | 2010-05-19 |
| Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer (NCT01127373) | Memorial Sloan Kettering Cancer Center | 2010-05-11 |